Pictured: Dan Douer
Video
By Memorial Sloan Kettering  |  Wednesday, April 10, 2013

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Pictured: José Baselga
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 8, 2013

Memorial Sloan Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Pictured: Jedd Wolchok
In the Clinic
By Media Staff  |  Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Pictured: Marc Ladanyi & Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, April 3, 2013

A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies.

Pictured: Paul Sabbatini
Q&A
By Media Staff  |  Tuesday, April 2, 2013

In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan Kettering’s clinical research program.

Pictured: Kenneth Offit
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Pictured: Yukio Sonoda
Video
By Memorial Sloan Kettering  |  Wednesday, March 27, 2013

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan Kettering have the benefit of an entire team of physicians having input into their care.

Pictured: Cycle for Survival
Event
By Jim Stallard, MA, Writer/Editor  |  Monday, March 25, 2013

The indoor cycling fund-raiser, in its seventh year, has raised more than $31 million for rare cancer research at Memorial Sloan Kettering.

Pictured: Ron Kraemer
Patient Story
By Memorial Sloan Kettering  |  Friday, March 22, 2013

To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan Kettering for care and support that could keep him playing music and working as a personal fitness trainer.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, March 20, 2013

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

Pictured: Stephen Chung
Video
By Memorial Sloan Kettering  |  Monday, March 18, 2013

Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.

Pictured: Peter Scardino
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Pictured: ESK1 Monoclonal Antibody
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, March 13, 2013

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: Dennis Chi & Richard Barakat
Q&A
By Allyson Collins, MS, Science Writer/Editor  |  Tuesday, March 12, 2013

Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.

Pictured: John Mulhall
Q&A
By Media Staff  |  Friday, March 8, 2013

Dr. Mulhall, director of Memorial Sloan Kettering’s Male Sexual and Reproductive Medicine Program, explains common concerns about male sexual health and offers advice for men and their partners.

Center News

Stay Informed

Get the latest information about cancer care and research every month.